Tinea Cruris
📧 Sign up to get email alerts when something new happens for Tinea Cruris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis [Phase 4]
Phase 4 pharmacokinetic study in pediatric patients with tinea pedis and tinea cruris has completed and results were posted.
-
FDA label_change · 2016-06-07FDA Approved: LUZU — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for LUZU (luliconazole) to update its labeling.
-
FDA approval · 2016-03-07FDA Approved: OXICONAZOLE NITRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Oxiconazole Nitrate topical product from Sun Pharmaceutical Industries, Inc. This generic antifungal is indicated for common fu…
-
FDA approval · 2016-02-25FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Ciclopirox olamine to update labeling and support use for common superficial fungal skin infecti…
-
FDA approval · 2016-01-06FDA Approved: NAFTIFINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's Naftifine hydrochloride under an Original Application; it is a topical antifungal indicated for tinea corp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-10-30FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved Glenmark's generic topical combination of clotrimazole and betamethasone dipropionate (ANDA 202894). It is indicated for inflam…
-
FDA approval · 2015-10-14FDA Approved: CICLOPIROX — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Ciclopirox from Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's labeli…
-
FDA approval · 2015-10-08FDA Approved: CICLOPIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Ciclopirox from Sun Pharmaceutical Industries, Inc., under the ANDA framework. The approval indi…
-
FDA approval · 2015-09-11FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approves a supplemental application for clotrimazole and betamethasone dipropionate (topical antifungal with corticosteroid) from E. Fou…
-
FDA approval · 2015-08-25FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for terbinafine hydrochloride (NorthStar Rx LLC). This action updates labeling/indications for the p…
-
FDA approval · 2015-08-19FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Oxistat (oxiconazole nitrate) from ANI Pharmaceuticals, Inc.
-
FDA approval · 2015-07-15FDA Approved: ECONAZOLE NITRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for econazole nitrate from Sun Pharmaceutical Industries, Inc., resulting in an approved update rela…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Naftin 1% Cream in adolescents with tinea cruris has completed.
-
FDA approval · 2015-03-03FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals. The update modifies the labe…
-
FDA label_change · 2015-01-26FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals, Inc.
-
FDA approval · 2015-01-05FDA Approved: CLOTRIMAZOLE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for clotrimazole submitted by Rite Aid Corporation, indicating an updated/expanded approval for this…
-
FDA approval · 2014-12-01FDA Approved: CICLOPIROX — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Ciclopirox from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2014-11-24FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)
The FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) by Voyant Beauty Inc., indicating regulatory cl…
-
FDA approval · 2014-10-22FDA Approved: SILKA JOCK ITCH — Supplemental Application (Genomma Lab USA, Inc.)
FDA approved a supplemental application for SILKA JOCK ITCH (terbinafine hydrochloride), updating the label for the antifungal to support it…
-
FDA approval · 2014-10-10FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc.
-
FDA approval · 2014-09-24FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approves a supplemental application for Naftin (naftifine hydrochloride) by Legacy Pharma USA Inc., resulting in labeling updates throug…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai [Phase 2]
This clinical trial update reports the completion of Phase 2 evaluation of Kandhaga Rasayanam in Padarthamarai for various tinea infections,…
-
FDA approval · 2014-01-09FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC via an Original Application.
-
FDA approval · 2013-11-14FDA Approved: LUZU — Original Application (Bausch Health US, LLC)
FDA approved LUZU (luliconazole) as a topical antifungal for the treatment of superficial fungal infections of the skin caused by dermatophy…
-
FDA approval · 2013-11-13FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc.